Cargando…

Taspase 1: A protease with many biological surprises

Taspase 1 (TASP1) cleaves the mixed-lineage leukemia (MLL) and transcription factor (TF) IIA families of nuclear proteins to orchestrate various biological processes. TASP1 is not a classical oncogene, but assists in cell proliferation and permits oncogenic initiation through cleavage of MLL and TFI...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niizuma, Hidetaka, Cheng, Emily H, Hsieh, James J
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Taylor & Francis 2015
Materias:	Author's View
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4905357/ https://www.ncbi.nlm.nih.gov/pubmed/27308523 http://dx.doi.org/10.1080/23723556.2014.999513

Ejemplares similares

Taspase1 orchestrates fetal liver hematopoietic stem cell and vertebrae fates by cleaving TFIIA
por: Niizuma, Hidetaka, et al.
Publicado: (2021)

Differentiation therapy for glioblastoma – too many obstacles?
por: Carén, Helena, et al.
Publicado: (2015)

The many flavors of tumor-associated B cells
por: Marits, Per, et al.
Publicado: (2013)

Oxysterols recruit tumor-supporting neutrophils within the tumor microenvironment: The many facets of tumor-derived oxysterols
por: Raccosta, Laura, et al.
Publicado: (2013)

Taspase1 cleaves MLL1 to activate cyclin E for HER2/neu breast tumorigenesis
por: Dong, Yiyu, et al.
Publicado: (2014)

Lon protease: A key enzyme controlling mitochondrial bioenergetics in cancer
por: Quirós, Pedro M, et al.
Publicado: (2014)

CTLs regulate tumor growth via cytostatic effects rather than cytotoxicity: a few T cells can influence the growth of many times more tumor cells
por: Kakimi, Kazuhiro, et al.
Publicado: (2014)

Notch and TGFβ: Functional partners facilitating tumor progression
por: Ohnuki, Hidetaka, et al.
Publicado: (2014)

A novel actor in antitumoral immunity: The thymus-specific serine protease TSSP/PRSS16 involved in CD4(+) T-cell maturation
por: Brisson, Lydie, et al.
Publicado: (2015)

Cell-in-cell: A virgin land of cell biology
por: Wang, Ying, et al.
Publicado: (2013)

Bioassays to Monitor Taspase1 Function for the Identification of Pharmacogenetic Inhibitors
por: Knauer, Shirley K., et al.
Publicado: (2011)

Function-first antibody discovery: Embracing the unpredictable biology of antibodies
por: Frendéus, Björn
Publicado: (2013)

The Taspase1/Myosin1f-axis regulates filopodia dynamics
por: Hensel, Astrid, et al.
Publicado: (2022)

Synthetic biology: the many facets of T7 RNA polymerase
por: Shis, David L, et al.
Publicado: (2014)

CircZNF609 as a prototype to elucidate the biological function of circRNA-mRNA interactions
por: Beltran, Manuel, et al.
Publicado: (2022)

Structural Characterization of the Loop at the Alpha-Subunit C-Terminus of the Mixed Lineage Leukemia Protein Activating Protease Taspase1
por: van den Boom, Johannes, et al.
Publicado: (2016)

LSD1 inhibitors disrupt the GFI1 transcription repressor complex
por: Maiques-Diaz, Alba, et al.
Publicado: (2018)

BRCA1: a movement toward cancer prevention
por: Alli, Elizabeth, et al.
Publicado: (2015)

A scientific journey from discovery to validation of efficacy in cancer patients: HAMLET and alpha1-oleate
por: Ho, James C.S., et al.
Publicado: (2021)

Overexpression of the Catalytically Impaired Taspase1(T234V) or Taspase1(D233A) Variants Does Not Have a Dominant Negative Effect in T(4;11) Leukemia Cells
por: Bier, Carolin, et al.
Publicado: (2012)

Key role of the positive feedback between PGE(2) and COX2 in the biology of myeloid-derived suppressor cells
por: Obermajer, Nataŝa, et al.
Publicado: (2012)

DGAT1 protects tumor from lipotoxicity, emerging as a promising metabolic target for cancer therapy
por: Cheng, Xiang, et al.
Publicado: (2020)

Dephosphorylation of the Atg1 kinase complex by type 2C protein phosphatases
por: Memisoglu, Gonen, et al.
Publicado: (2019)

Overexpression of Taspase 1 Predicts Poor Prognosis in Patients with Hepatocellular Carcinoma
por: Jiang, Jie, et al.
Publicado: (2021)

Targeting cancer stem cells with ALDH1A1-based immunotherapy
por: DeLeo, Albert B.
Publicado: (2012)

Blockade of PD-1 immunosuppression boosts CAR T-cell therapy
por: John, Liza B, et al.
Publicado: (2013)

The mitochondrial ATP synthase as an ATP consumer—a surprising therapeutic target
por: Valdebenito, Gabriel E, et al.
Publicado: (2023)

BRCA1-BARD1: the importance of being in shape
por: Daza-Martin, Manuel, et al.
Publicado: (2019)

A novel combinatorial cancer immunotherapy: poly-IC and blockade of the PD-1/PD-L1 pathway
por: Nagato, Toshihiro, et al.
Publicado: (2014)

The IL-15-based superagonist ALT-803 promotes the antigen-independent conversion of memory CD8(+) T cells into innate-like effector cells with antitumor activity
por: Wong, Hing C, et al.
Publicado: (2013)

DKK1 as a novel target for myeloma immunotherapy
por: Qian, Jianfei, et al.
Publicado: (2012)

Sestrin1, a tumor suppressor that can be rescued
por: Donaldson, Maria C., et al.
Publicado: (2017)

Expression profile of the human IDO1 protein, a cancer drug target involved in tumoral immune resistance
por: Vigneron, Nathalie, et al.
Publicado: (2015)

SAMHD1 is a barrier to antimetabolite-based cancer therapies
por: Rudd, Sean G., et al.
Publicado: (2017)

TFG: a novel regulator of ULK1-dependent autophagy
por: Cecconi, Francesco, et al.
Publicado: (2021)

ESR1 fusions drive endocrine therapy resistance and metastasis in breast cancer
por: Lei, Jonathan T., et al.
Publicado: (2018)

The BARD1/HP1 interaction: Another clue to heterochromatin involvement in homologous recombination
por: Fukuda, Takayo, et al.
Publicado: (2015)

Brca1 mutations in the coiled-coil domain impede Rad51 loading on DNA and mouse development
por: Krais, J. J., et al.
Publicado: (2020)

Serum HMGB1 is a predictive and prognostic biomarker for oncolytic immunotherapy
por: Liikanen, Ilkka, et al.
Publicado: (2015)

AMBRA1-induced mitophagy: A new mechanism to cope with cancer?
por: Strappazzon, Flavie, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_n01mkte0rsja5vsdnucshksc85